About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Articles

Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond

Citation:

Cardiac Failure Review 2020;6:e16.

Temporary Mechanical Circulatory Support in Acute Heart Failure

Published:

16 March 2020

Citation:

Cardiac Failure Review 2020;6:e01.

The Use of App-based Follow-up of Cardiac Implantable Electronic Devices

Citation:

Cardiac Failure Review 2020;6:e03.

Left Ventricular Assist Device Support Complicates the Exercise Physiology of Oxygen Transport and Uptake in Heart Failure

Citation:

Cardiac Failure Review 2019;5(3):162–8.